Loading...
Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis
Venetoclax is efficacious in relapsed/refractory t(11;14) multiple myeloma, thus warranting investigation in light-chain amyloidosis (AL). This retrospective cohort includes 43 patients with previously treated AL, from 14 centers in the US and Europe. Thirty-one patients harbored t(11;14), 11 did no...
Na minha lista:
| Udgivet i: | Blood Cancer J |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group UK
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7801694/ https://ncbi.nlm.nih.gov/pubmed/33431806 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-020-00397-w |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|